State Street Corp Rallybio Corp Transaction History
State Street Corp
- $2.36 Trillion
- Q1 2025
A detailed history of State Street Corp transactions in Rallybio Corp stock. As of the latest transaction made, State Street Corp holds 62,072 shares of RLYB stock, worth $20,483. This represents 0.0% of its overall portfolio holdings.
Number of Shares
62,072
Previous 62,072
-0.0%
Holding current value
$20,483
Previous $59,000
32.2%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding RLYB
# of Institutions
48Shares Held
32.4MCall Options Held
0Put Options Held
0-
Viking Global Investors LP4.19MShares$1.38 Million0.01% of portfolio
-
Johnson & Johnson New Brunswick, NJ3.64MShares$1.2 Million0.78% of portfolio
-
5 Am Venture Management, LLC San Francisco, CA3.63MShares$1.2 Million1.63% of portfolio
-
New Leaf Venture Partners, L.L.C. New York, NY3.3MShares$1.09 Million4.83% of portfolio
-
Tpg Gp A, LLC Fort Worth, TX3.03MShares$999,3760.06% of portfolio
About Rallybio Corp
- Ticker RLYB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 32,132,000
- Market Cap $10.6M
- Description
- Rallybio Corporation, a clinical-stage biotechnology company, engages in discovering, developing, manufacturing, and delivering therapies that enhance the lives of patients suffering from severe and rare diseases. Its lead product candidate is RLYB212, a monoclonal anti-HPA-1a antibody that is in Phase I clinical trial for the prevention of feta...